Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults, a cohort study

Annals of Internal Medicine

Volumn 158, Issue 7, 2013, Pages 515-525

  Mozaffarian, Dariush ^a   Lemaitre, Rozenn N ^b   King, Irena B ^c   Song, Xiaoling ^d   Huang, Hongyan ^a   Sacks, Frank M ^a   Rimm, Eric B ^a   Wang, Molin ^a   Siscovick, David S ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; OMEGA 3 FATTY ACID; PHOSPHOLIPID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; DEATH; FATALITY; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; UNITED STATES;

AGED; BIOLOGICAL MARKERS; CAUSE OF DEATH; CORONARY DISEASE; DIET RECORDS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FEMALE; FOOD HABITS; HUMANS; MALE; PROSPECTIVE STUDIES; RISK ASSESSMENT; STROKE;

EID: 84875727518     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-158-7-201304020-00003     Document Type: Article

References (58)

1. Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: ef-fects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011;58:2047-67.
2. Zheng J, Huang T, Yu Y, Hu X, Yang B, Li D. Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies. Public Health Nutr. 2012;15:725-37.
3. Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association be-tween omega-3 fatty acid supplementation and risk of major cardiovascular dis-ease events: a systematic review and meta-analysis. JAMA. 2012;308:1024-33.
4. Siscovick DS, Lemaitre RN, Mozaffarian D. The fish story: a diet-heart hypothesis with clinical implications: n-3 polyunsaturated fatty acids, myocardial vulnerability, and sudden death [Editorial]. Circulation. 2003;107:2632-4.
5. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296:1885-99.
6. Virtanen JK, Mozaffarian D, Chiuve SE, Rimm EB. Fish consumption and risk of major chronic disease in men. Am J Clin Nutr. 2008;88:1618-25.
7. Yuan JM, Ross RK, Gao YT, Yu MC. Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghai, China. Am J Epidemiol. 2001;154:809-16.
8. Folsom AR, Demissie Z. Fish intake, marine omega-3 fatty acids, and mor-tality in a cohort of postmenopausal women. Am J Epidemiol. 2004;160:1005-10.
9. Yamagishi K, Iso H, Date C, Fukui M, Wakai K, Kikuchi S, et al; Japan Collaborative Cohort Study for Evaluation of Cancer Risk Study Group. Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study. J Am Coll Cardiol. 2008;52:988-96.
10. Mozaffarian D, Wu JH. (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary? J Nutr. 2012;142:614S-625S.
11. Mozaffarian D, Lemaitre RN, King IB, Song X, Spiegelman D, Sacks FM, et al. Circulating long-chain ω-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study. Ann Intern Med. 2011;155:160-70.
12. Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP. Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem. 1995;41:264-70.
13. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1:263-76.
14. Kumanyika SK, Tell GS, Shemanski L, Martel J, Chinchilli VM. Dietary assessment using a picture-sort approach. Am J Clin Nutr. 1997;65:1123S-1129S.
15. Psaty BM, Kuller LH, Bild D, Burke GL, Kittner SJ, Mittelmark M, et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol. 1995;5:270-7.
16. Mukamal KJ, Chung H, Jenny NS, Kuller LH, Longstreth WT Jr, Mittle-man MA, et al. Alcohol consumption and risk of coronary heart disease in older adults: the Cardiovascular Health Study. J Am Geriatr Soc. 2006;54:30-7.
17. Geffken DF, Cushman M, Burke GL, Polak JF, Sakkinen PA, Tracy RP. Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol. 2001;153:242-50.
18. Kumanyika S, Tell GS, Fried L, Martel JK, Chinchilli VM. Picture-sort method for administering a food frequency questionnaire to older adults. J Am Diet Assoc. 1996;96:137-44.
19. Mozaffarian D, Bryson CL, Lemaitre RN, Burke GL, Siscovick DS. Fish intake and risk of incident heart failure. J Am Coll Cardiol. 2005;45:2015-21.
20. Ives DG, Fitzpatrick AL, Bild DE, Psaty BM, Kuller LH, Crowley PM, et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol. 1995;5:278-85.
21. Mozaffarian D, Lemaitre RN, Kuller LH, Burke GL, Tracy RP, Siscovick DS; Cardiovascular Health Study. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation. 2003;107:1372-7.
22. Mozaffarian D, Longstreth WT Jr, Lemaitre RN, Manolio TA, Kuller LH, Burke GL, et al. Fish consumption and stroke risk in elderly individuals: the cardiovascular health study. Arch Intern Med. 2005;165:200-6.
23. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8:551-61.
24. Breslow NE. Discussion of "Covariance analysis of censored survival data," by D.R. Cox. J R Stat Soc Series B Stat Methodol. 1972;34:216-7.
25. Efron B. Bootstrap methods: another look at the jackknife. Ann Stat. 1979; 7:1-26.
26. Cox DR, Oakes D. Analysis of Survival Data. London: Chapman & Hall; 1984.
27. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortal-ity: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-13.
28. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, et al; Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 pro-spective studies with 55, 000 vascular deaths. Lancet. 2007;370:1829-39.
29. Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150:341-53.
30. Rosner B, Spiegelman D, Willett WC. Correction of logistic regression relative risk estimates and confidence intervals for random within-person mea-surement error. Am J Epidemiol. 1992;136:1400-13.
31. Sun Q, Ma J, Campos H, Rexrode KM, Albert CM, Mozaffarian D, et al. Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction. Am J Clin Nutr. 2008;88:216-23.
32. Fredman G, Serhan CN. Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. Biochem J. 2011; 437:185-97.
33. Imig JD, Hammock BD. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discov. 2009;8:794-805.
34. Johnston CS, Cox SK. Plasma-Saturating intakes of vitamin C confer max-imal antioxidant protection to plasma. J Am Coll Nutr. 2001;20:623-7.
35. Roberts LJ 2nd, Oates JA, Linton MF, Fazio S, Meador BP, Gross MD, et al. The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic Biol Med. 2007;43:1388-93.
36. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA. 1995; 274:1363-7.
37. Wu JH, Lemaitre RN, King IB, Song X, Sacks FM, Rimm EB, et al. Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study. Circulation. 2012;125: 1084-93.
38. Harris WS, Sands SA, Windsor SL, Ali HA, Stevens TL, Magalski A, et al. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: cor-relation with erythrocytes and response to supplementation. Circulation. 2004; 110:1645-9.
39. Virtanen JK, Mursu J, Voutilainen S, Tuomainen TP. Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men. Circulation. 2009;120:2315-21.
40. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, et al; Japan EPA Lipid Intervention Study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007;369: 1090-8.
41. Mayurasakorn K, Williams JJ, Ten VS, Deckelbaum RJ. Docosahexaenoic acid: brain accretion and roles in neuroprotection after brain hypoxia and isch-emia. Curr Opin Clin Nutr Metab Care. 2011;14:158-67.
42. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Per-spective. Washington, DC: American Institute for Cancer Research; 2007.
43. Fotuhi M, Mohassel P, Yaffe K. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex associa-tion. Nat Clin Pract Neurol. 2009;5:140-52.
44. Anandan C, Nurmatov U, Sheikh A. Omega 3 and 6 oils for primary prevention of allergic disease: systematic review and meta-analysis. Allergy. 2009; 64:840-8.
45. Saini A, Harjai K, Chhibber S. Sea-cod oil supplementation alters the course of Streptococcus pneumoniae infection in BALB/c mice. Eur J Clin Microbiol Infect Dis. 2011;30:393-400.
46. Tiesset H, Bernard H, Bartke N, Beermann C, Flachaire E, Desseyn JL, et al. (n-3) long-chain PUFA differentially affect resistance to Pseudomonas aeruginosa infection of male and female cftr-/-mice. J Nutr. 2011;141:1101-7.
47. Pontes-Arruda A, Demichele S, Seth A, Singer P. The use of an inflammation-modulating diet in patients with acute lung injury or acute respi-ratory distress syndrome: a meta-analysis of outcome data. JPEN J Parenter En-teral Nutr. 2008;32:596-605.
48. Pontes-Arruda A, Martins LF, de Lima SM, Isola AM, Toledo D, Rezende E, et al; Investigating Nutritional Therapy with EPA, GLA and Antioxidants Role in Sepsis Treatment (INTERSEPT) Study Group. Enteral nutrition with eicosapentaenoic acid, γ-linolenic acid and antioxidants in the early treatment of sepsis: results from a multicenter, prospective, randomized, double-blinded, controlled study: the INTERSEPT study. Crit Care. 2011;15:R144.
49. Rice TW, Wheeler AP, Thompson BT, deBoisblanc BP, Steingrub J, Rock P; NIH NHLBI Acute Respiratory Distress Syndrome Network of Investiga-tors. Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supple-mentation in acute lung injury. JAMA. 2011;306:1574-81.
50. Aarsetoey H, Pönitz V, Grundt H, Staines H, Harris WS, Nilsen DW. (n-3) fatty acid content of red blood cells does not predict risk of future cardio-vascular events following an acute coronary syndrome. J Nutr. 2009;139:507-13.
51. Erkkila ÄT, Lehto S, Pyörälä K, Uusitupa MI. n-3 fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease. Am J Clin Nutr. 2003;78:65-71.
52. Lee SH, Shin MJ, Kim JS, Ko YG, Kang SM, Choi D, et al. Blood eicosapentaenoic acid and docosahexaenoic acid as predictors of all-cause mortal-ity in patients with acute myocardial infarction-data from Infarction Prognosis Study (IPS) Registry. Circ J. 2009;73:2250-7.
53. Pottala JV, Garg S, Cohen BE, Whooley MA, Harris WS. Blood eicosa-pentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the Heart and Soul study. Circ Cardiovasc Qual Outcomes. 2010;3:406-12.
54. Lindberg M, Saltvedt I, Sletvold O, Bjerve KS. Long-chain n-3 fatty acids and mortality in elderly patients. Am J Clin Nutr. 2008;88:722-9.
55. Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, Gordon D, et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supple-ments for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials. 2012;33:159-71.
56. Lemaitre RN, King IB, Mozaffarian D, Kuller LH, Tracy RP, Siscovick DS. n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. Am J Clin Nutr. 2003;77:319-25.
57. Zucker DM, Spiegelman D. Inference for the proportional hazards model with misclassified discrete-valued covariates. Biometrics. 2004;60:324-34.
58. Zucker DM, Spiegelman D. Corrected score estimation in the proportional hazards model with misclassified discrete covariates. Stat Med. 2008;27:1911-33.